{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:19:58Z","timestamp":1792063198259,"version":"4.4.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004852","name":"Sumy State University","doi-asserted-by":"publisher","award":["0119U100887"],"award-info":[{"award-number":["0119U100887"]}],"id":[{"id":"10.13039\/501100004852","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007684","name":"Ministry of Education and Science of Ukraine","doi-asserted-by":"publisher","award":["0121U100472"],"award-info":[{"award-number":["0121U100472"]}],"id":[{"id":"10.13039\/501100007684","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.prp.2022.154082","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T15:02:44Z","timestamp":1660748564000},"page":"154082","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["COX2 Effects on endometrial carcinomas progression"],"prefix":"10.1016","volume":"238","author":[{"given":"M.","family":"Lyndin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Kravtsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu.","family":"Lyndina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye.","family":"Kuzenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.A.","family":"Awuah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Abdul-Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hyriavenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Romaniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.prp.2022.154082_bib1","first-page":"S105","article-title":"Carcinoma of the Corpus Uteri","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J. Gynaecol. Obstet."},{"key":"10.1016\/j.prp.2022.154082_bib2","first-page":"136","article-title":"The role of hsp70 and hsp90 in the endometrial carcinomas progression","volume":"3","author":"Kravtsova","year":"2021","journal-title":"Azerbaijan Med. J."},{"key":"10.1016\/j.prp.2022.154082_bib3","first-page":"160","article-title":"Morphofunctional changes in endometrium under the influence of chronic alcoholism","volume":"315","author":"Lytvynenko","year":"2021","journal-title":"Georgian Med. N."},{"issue":"5","key":"10.1016\/j.prp.2022.154082_bib4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.prp.2017.01.003","article-title":"Primary multiple tumor with affection of the thyroid gland, uterus, urinary bladder, mammary gland and other organs","volume":"213","author":"Romaniuk","year":"2017","journal-title":"Pathol. Res. Pr."},{"issue":"5","key":"10.1016\/j.prp.2022.154082_bib5","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1002\/jcp.27411","article-title":"Cyclooxygenase-2 in cancer: a review","volume":"234","author":"Hashemi Goradel","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"4","key":"10.1016\/j.prp.2022.154082_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3390\/ph11040101","article-title":"Cyclooxygenase-1 (COX-1) and COX-1 inhibitors in cancer: a review of oncology and medicinal chemistry literature","volume":"11","author":"Pannunzio","year":"2018","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.prp.2022.154082_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cbi.2017.08.014","article-title":"miR-221\/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt\/NF-\u03baB\/COX-2 activation","volume":"277","author":"Li","year":"2017","journal-title":"Chem. Biol. Inter."},{"issue":"5","key":"10.1016\/j.prp.2022.154082_bib8","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1002\/jcp.27411","article-title":"Cyclooxygenase-2 in cancer: a review","volume":"234","author":"Hashemi Goradel","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"37","key":"10.1016\/j.prp.2022.154082_bib9","doi-asserted-by":"crossref","first-page":"58953","DOI":"10.18632\/oncotarget.9835","article-title":"Crosstalk between osteoprotegerin (OPG), fatty acid synthase (FASN) and, cycloxygenase-2 (COX-2) in breast cancer: implications in carcinogenesis","volume":"7","author":"Goswami","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.prp.2022.154082_bib10","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cellsig.2015.01.014","article-title":"HGF-activated colonic fibroblasts mediates carcinogenesis of colonic epithelial cancer cells via PKC-cMET-ERK1\/2-COX-2 signaling","volume":"27","author":"Li","year":"2015","journal-title":"Cell Signal"},{"issue":"12","key":"10.1016\/j.prp.2022.154082_bib11","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1039\/C7DT04790H","article-title":"Chlorinated cobalt alkyne complexes derived from acetylsalicylic acid as new specific antitumor agents","volume":"47","author":"Obermoser","year":"2018","journal-title":"Dalton Trans."},{"issue":"2","key":"10.1016\/j.prp.2022.154082_bib12","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1200\/JCO.2005.09.112","article-title":"Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention","volume":"23","author":"Dannenberg","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2022.154082_bib13","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1021\/acs.analchem.7b05337","article-title":"Celecoxib conjugated fluorescent probe for identification and discrimination of cyclooxygenase-2 enzyme in cancer cells","volume":"90","author":"Gurram","year":"2018","journal-title":"Anal. Chem."},{"issue":"3","key":"10.1016\/j.prp.2022.154082_bib14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ajpath.2017.10.025","article-title":"The presence of cyclooxygenase 2, tumor-associated macrophages, and collagen alignment as prognostic markers for invasive breast carcinoma patients","volume":"188","author":"Esbona","year":"2018","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2022.154082_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/carcin\/bgp014","article-title":"The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment","volume":"30","author":"Greenhough","year":"2009","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.prp.2022.154082_bib16","first-page":"21","article-title":"Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in ovarian cancer","volume":"15","author":"Fujimoto","year":"2006","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2022.154082_bib17","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.biopha.2017.12.111","article-title":"Anti-inflammatory and anti-tumor effects of \u03b1-l-guluronic acid (G2013) on cancer-related inflammation in a murine breast cancer model","volume":"98","author":"Hosseini","year":"2018","journal-title":"Biomed. Pharm."},{"issue":"6","key":"10.1016\/j.prp.2022.154082_bib18","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/1541-7786.MCR-14-0543","article-title":"COX-2 elevates oncogenic miR-526b in breast cancer by EP4 activation","volume":"13","author":"Majumder","year":"2015","journal-title":"Mol. Cancer Res."},{"issue":"11","key":"10.1016\/j.prp.2022.154082_bib19","doi-asserted-by":"crossref","first-page":"17981","DOI":"10.18632\/oncotarget.14912","article-title":"Breast cancer cell cyclooxygenase-2 expression alters extracellular matrix structure and function and numbers of cancer associated fibroblasts","volume":"8","author":"Krishnamachary","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.prp.2022.154082_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12885-018-4250-8","article-title":"Knockdown delta-5-desaturase in breast cancer cells that overexpress COX-2 results in inhibition of growth, migration and invasion via a dihomo-\u03b3-linolenic acid peroxidation dependent mechanism","volume":"18","author":"Xu","year":"2018","journal-title":"BMC Cancer"},{"issue":"52","key":"10.1016\/j.prp.2022.154082_bib21","doi-asserted-by":"crossref","first-page":"89802","DOI":"10.18632\/oncotarget.21155","article-title":"Prostaglandin E2 and PD-1 mediated inhibition of antitumor CTL responses in the human tumor microenvironment","volume":"8","author":"Miao","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.prp.2022.154082_bib22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/ERC-17-0376","article-title":"Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells","volume":"25","author":"Chin","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"issue":"11","key":"10.1016\/j.prp.2022.154082_bib23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s005350200151","article-title":"Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines","volume":"37","author":"Noda","year":"2002","journal-title":"J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.prp.2022.154082_bib24","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1038\/s41598-018-20572-1","article-title":"Functional loss of p53 cooperates with the in vivo microenvironment to promote malignant progression of gastric cancers","volume":"8","author":"Ohtsuka","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2022.154082_bib25","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1038\/s41598-017-06253-5","article-title":"Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc Min\/+ mouse model of intestinal tumorigenesis","volume":"7","author":"Hull","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2022.154082_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/nyas.13423","article-title":"Mechanisms of action of nonpeptide hormones on resveratrol-induced antiproliferation of cancer cells","volume":"1403","author":"Lin","year":"2017","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"13","key":"10.1016\/j.prp.2022.154082_bib27","doi-asserted-by":"crossref","first-page":"6657","DOI":"10.1158\/0008-5472.CAN-05-3624","article-title":"Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis","volume":"66","author":"Xu","year":"2006","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2022.154082_bib28","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1124\/mol.104.002618","article-title":"Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells","volume":"66","author":"Hinz","year":"2004","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.prp.2022.154082_bib29","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/078538902321012379","article-title":"The expression of cyclooxygenase-1 and -2 in proliferative endometrium and endometrial adenocarcinoma","volume":"34","author":"Uotila","year":"2002","journal-title":"Ann. Med."},{"issue":"6A","key":"10.1016\/j.prp.2022.154082_bib30","first-page":"3679","article-title":"Multiple roles of cyclooxygenase-2 in endometrial cancer","volume":"25","author":"Ohno","year":"2005","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.prp.2022.154082_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4314\/ovj.v10i2.5","article-title":"Endometritis in the bitch: Immunohistochemical localization of cyclooxygenase 2","volume":"10","author":"Mitacek","year":"2020","journal-title":"Open Vet. J."},{"issue":"6","key":"10.1016\/j.prp.2022.154082_bib32","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00404-020-05559-6","article-title":"COX-2-PGE2-EPs in gynecological cancers","volume":"301","author":"Ye","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"issue":"6A","key":"10.1016\/j.prp.2022.154082_bib33","first-page":"3679","article-title":"Multiple roles of cyclooxygenase-2 in endometrial cancer","volume":"25","author":"Ohno","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.prp.2022.154082_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fonc.2020.00056","article-title":"Cyclooxygenase-2 and \u03b2-catenin as potential diagnostic and prognostic markers in endometrial cancer","volume":"10","author":"Deng","year":"2020","journal-title":"Front. Oncol."},{"issue":"1\u20132","key":"10.1016\/j.prp.2022.154082_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11010-018-3313-0","article-title":"MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma","volume":"448","author":"Liu","year":"2018","journal-title":"Mol. Cell Biochem."},{"issue":"11","key":"10.1016\/j.prp.2022.154082_bib36","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/dc.24481","article-title":"Expression of cyclooxygenase-2 in imprint smears of endometrial carcinoma","volume":"48","author":"Kosmas","year":"2020","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.prp.2022.154082_bib37","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.3389\/fonc.2020.01202","article-title":"Prognostic and clinical significance of cyclooxygenase-2 overexpression in endometrial cancer: a meta-analysis","volume":"10","author":"Li","year":"2020","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2022.154082_bib38","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1007\/s13277-013-0991-9","article-title":"Altered expression of ERs, aromatase, and COX2 connected to estrogen action in type 1 endometrial cancer biology","volume":"34","author":"Jarzabek","year":"2013","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.prp.2022.154082_bib39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1309\/AJCPV7U7PGHOWEQG","article-title":"NF-\u03baB and COX-2 expression in nonmalignant endometrial lesions and cancer","volume":"141","author":"Faloppa","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2022.154082_bib40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2017.04.025","article-title":"The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer","volume":"400","author":"Brizzolara","year":"2017","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.prp.2022.154082_bib41","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1038\/s41598-017-06253-5","article-title":"Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc Min\/+ mouse model of intestinal tumorigenesis","volume":"7","author":"Hull","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.prp.2022.154082_bib42","first-page":"71","article-title":"Primary cancer of the fallopian tubes: histological and immunohistochemical features","volume":"56","author":"Romaniuk","year":"2016","journal-title":"Folia Med. Cracov."},{"key":"10.1016\/j.prp.2022.154082_bib43","series-title":"WHO Classification of Tumours of Female Reproductive Organs","first-page":"307","year":"2014"},{"issue":"3","key":"10.1016\/j.prp.2022.154082_bib44","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.prp.2022.154082_bib45","first-page":"63","article-title":"Pathogenetic mechanisms of heavy metals effect on proapoptotic and proliferative potential of breast cancer","volume":"7","author":"Romaniuk","year":"2015","journal-title":"Inter. Med. Appl. Sci."},{"key":"10.1016\/j.prp.2022.154082_bib46","first-page":"53","article-title":"Indicators of proliferative activity of endometrium in women with immunodeficiency","volume":"2","author":"Lytvynenko","year":"2021","journal-title":"AMJ"},{"issue":"2","key":"10.1016\/j.prp.2022.154082_bib47","doi-asserted-by":"crossref","first-page":"119","DOI":"10.26641\/2307-0404.2022.2.260284","article-title":"Triple-negative transformation of the endometrium, cervix and mammary gland on the background of immunodeficiency","volume":"27","author":"Lytvynenko","year":"2022","journal-title":"Med. Perspekt."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822003260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822003260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:53:52Z","timestamp":1759733632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822003260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":47,"alternative-id":["S0344033822003260"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.154082","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COX2 Effects on endometrial carcinomas progression","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.154082","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"154082"}}